Skip to content

Carnitine Supplementation and Bone Mineral Density

Effect of Carnitine Supplementation and Resistance Training on Bone Mineral Density

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05120011
Enrollment
36
Registered
2021-11-15
Start date
2017-09-01
Completion date
2018-07-07
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

The primary aim of the current research project is to explore whether carnitine supplementation and resistance training may prevent decrements in bone mineral density of aged women. A secondary aim of this project is to investigate the effect of supplementation on body composition and blood markers.

Detailed description

The study includes postmenopausal women. The subjects participate in resistance training (twice a week) for each session consisted of 6 exercises: horizontal seated leg press, seated chest press, leg extension, shoulder press, lat pull-down seated row, seated cable row. During the 24-weeks training programme participants are supplemented by carnitine with leucine, or leucine alone (placebo).

Interventions

DIETARY_SUPPLEMENTL-carnitine

L-carnitine-L-tartrate

DIETARY_SUPPLEMENTL-leucine

L-leucine

Sponsors

Medical University of Gdansk
CollaboratorOTHER
Poznan University of Physical Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* postmenopausal * lack of restrictions to perform resistance exercises

Exclusion criteria

* cardiovascular disease * liver disease * kidney disease * neuromuscular disease * gastrointestinal disorders (including stomach ulcers and erosions) * diabetes * other severe chronic diseases

Design outcomes

Primary

MeasureTime frameDescription
Bone Mineral Density measured by dual-energy X-ray absorptiometry (DXA)24 weeksBone mineral density (BMD) of the femoral neck, lumbar vertebrae L1-L4, and total hip determined by Lunar Prodigy Advance DXA (GE, Healthcare, Madison, Wisconsin, USA).

Secondary

MeasureTime frameDescription
Body Composition: Body Fat Mass, Fat Free Mass, and Skeletal Muscle Mass using a bioelectrical impedance analyzer (InBody720).24 weeksThe InBody720 measures impedance of five segments of the body (each arm, each leg, trunk) at frequencies of 1, 5, 50, 250, 500, and 1000 kHz through the 8-polar tactile-electrode. Based on the impedance, body fat mass, fat free mass, and skeletal muscle mass are calculated.
The circulating markers modification24 weeksDetermination of serum interleukin-6, tumor necrosis factor alpha, C-reactive protein, and plasma trimethylamine N-oxide.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026